Volume 5, Number 6—December 1999
Synopsis
Antimicrobial Resistance with Streptococcus pneumoniae in the United States, 1997–98
Gary V. Doern
, Angela B. Brueggemann, Holly Huynh, Elizabeth Wingert, and Paul Rhomberg
, Angela B. Brueggemann, Holly Huynh, Elizabeth Wingert, and Paul RhombergTable 3
Recovery of Streptococcus pneumoniae strains with intermediate and high levels of resistance, by specimen source and patient characteristics
| Characteristic | Total no. of isolates | No. (%) of resistant isolates for the following antimicrobial drugs |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Penicillin |
Ceftriaxone |
Erythromycin |
Tetracycline |
TMP/SMX Chloramphenicol |
|||||||||
| I | R | I | R | I | R | I | R | I | R | I | R | ||
| Specimen sourcea | |||||||||||||
| LRT | 773 | 144 | 103 | 91 | 36 | 5 | 152 | 1 | 116 | 89 | 149 | -- | 67 |
| (18.6) | (13.3) | (11.8) | (4.7) | (0.6) | (20.9) | (0.1) | (15.0) | (11.5) | (19.3) | (8.7) | |||
| Blood | 509 | 68 | 41 | 35 | 16 | 1 | 59 | 2 | 33 | 40 | 87 | -- | 17 |
| (13.4) | (8.1) | (6.9) | (3.1) | (0.2) | (11.6) | (0.4) | (6.5) | (7.9) | (17.1) | (3.3) | |||
| URT | 238 | 50 | 48 | 44 | 11 | 0 | 77 | 2 | 53 | 28 | 74 | -- | 28 |
| (21.0) | (20.2) | (18.5) | (4.6) | (0.0) | (32.4) | (0.8) | (22.3) | (11.8) | (31.1) | (11.8) | |||
| BF/CSF | 60 | 12 | 3 | 4 | 1 | 0 | 9 | 0 | 3 | 1 | 13 | -- | 2 |
| (20.0) | (5.0) | (6.7) | (1.7) | (0.0) | (15.0) | (0.0) | (5.0) | (1.7) | (21.7) | (3.3) | |||
| Other | 21 | 4 | 1 | 1 | 0 | 0 | 5 | 0 | 1 | 2 | 3) | -- | 1 |
| (19.0) | (4.8) | (4.8) | (0.0) | (0.0) | (23.8) | (0.0) | (4.8) | (9.5) | (14.3) | (4.8) | |||
| Age group (years) | |||||||||||||
| <5 | 432 | 88 | 79 | 72 | 23 | 1 | 115 | 3 | 71 | 62 | 128 | -- | 42 |
| (20.4) | (18.3) | (16.7) | (5.3) | (0.2) | (26.6) | (0.7) | (16.4) | (14.4) | (29.6) | (9.7) | |||
| 6-20 | 97 | 14 | 6 | 6 | 1 | 0 | 12 | 0 | 11 | 11 | 14 | -- | 4 |
| (14.4) | (6.2) | (6.2) | (1.0) | (0.0) | (12.4) | (0.0) | (11.3) | (11.3) | (14.4) | (4.1) | |||
| 21-50 | 407 | 76 | 42 | 39 | 18 | 2 | 71 | 0 | 56 | 32 | 80 | -- | 22 |
| (18.7) | (10.6) | (9.6) | (4.4) | (0.5) | (17.4) | (0.0) | (13.8) | (7.9) | (19.7) | (5.4) | |||
| >50 | 652 | 96 | 68 | 57 | 22 | 3 | 102 | 2 | 66 | 65 | 102 | -- | 46 |
| (14.7) | (10.4) | (8.7) | (3.4) | (0.5) | (15.6) | (0.3) | (10.1) | (10.0) | (15.6) | (7.1) | |||
| Service | |||||||||||||
| Inpatient | 969 | 172 | 111 | 104 | 37 | 3 | 171 | 3 | 107 | 85 | 192 | -- | 61 |
| (17.8) | (11.5) | (10.7) | (3.8) | (0.3) | (17.6) | (0.3) | (11.0) | (8.8) | (19.8) | (6.3) | |||
| Outpatient | 628 | 106 | 85 | 71 | 27 | 3 | 131 | 2 | 99 | 86 | 134 | -- | 54 |
| (16.9) | (13.5) | (11.3) | (4.3) | (0.3) | (20.9) | (0.3) | (15.8) | (13.7) | (21.3) | (8.6) | |||
aBF/CSF, body fluids/cerebrospinal fluid; LRT, lower respiratory tract; URT = upper respiratory tract.
TMP/SMX, trimethoprim/sulfamethoxazole.
